Cargando…
Potential use of ubiquinol and d-ribose in patients with heart failure with preserved ejection fraction
• Manuscript Highlights. • HFpEF is associated with reduced ATP production in the myocardium. • Ubiquinol and d-ribose both contribute to the generation of myocardial ATP. • Both ubiquinol and d-ribose are being studied as supplemental treatments for patients with HFpEF.
Autores principales: | , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7251495/ https://www.ncbi.nlm.nih.gov/pubmed/32477499 http://dx.doi.org/10.1016/j.amsu.2020.05.009 |
_version_ | 1783538977994702848 |
---|---|
author | Pierce, Janet D. Shen, Qiuhua Vacek, James Rahman, Faith K. Krueger, Kathryn J. Gupta, Bhanu Hiebert, John B. |
author_facet | Pierce, Janet D. Shen, Qiuhua Vacek, James Rahman, Faith K. Krueger, Kathryn J. Gupta, Bhanu Hiebert, John B. |
author_sort | Pierce, Janet D. |
collection | PubMed |
description | • Manuscript Highlights. • HFpEF is associated with reduced ATP production in the myocardium. • Ubiquinol and d-ribose both contribute to the generation of myocardial ATP. • Both ubiquinol and d-ribose are being studied as supplemental treatments for patients with HFpEF. |
format | Online Article Text |
id | pubmed-7251495 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | Elsevier |
record_format | MEDLINE/PubMed |
spelling | pubmed-72514952020-05-29 Potential use of ubiquinol and d-ribose in patients with heart failure with preserved ejection fraction Pierce, Janet D. Shen, Qiuhua Vacek, James Rahman, Faith K. Krueger, Kathryn J. Gupta, Bhanu Hiebert, John B. Ann Med Surg (Lond) Review Article • Manuscript Highlights. • HFpEF is associated with reduced ATP production in the myocardium. • Ubiquinol and d-ribose both contribute to the generation of myocardial ATP. • Both ubiquinol and d-ribose are being studied as supplemental treatments for patients with HFpEF. Elsevier 2020-05-18 /pmc/articles/PMC7251495/ /pubmed/32477499 http://dx.doi.org/10.1016/j.amsu.2020.05.009 Text en © 2020 The Authors http://creativecommons.org/licenses/by-nc-nd/4.0/ This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/). |
spellingShingle | Review Article Pierce, Janet D. Shen, Qiuhua Vacek, James Rahman, Faith K. Krueger, Kathryn J. Gupta, Bhanu Hiebert, John B. Potential use of ubiquinol and d-ribose in patients with heart failure with preserved ejection fraction |
title | Potential use of ubiquinol and d-ribose in patients with heart failure with preserved ejection fraction |
title_full | Potential use of ubiquinol and d-ribose in patients with heart failure with preserved ejection fraction |
title_fullStr | Potential use of ubiquinol and d-ribose in patients with heart failure with preserved ejection fraction |
title_full_unstemmed | Potential use of ubiquinol and d-ribose in patients with heart failure with preserved ejection fraction |
title_short | Potential use of ubiquinol and d-ribose in patients with heart failure with preserved ejection fraction |
title_sort | potential use of ubiquinol and d-ribose in patients with heart failure with preserved ejection fraction |
topic | Review Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7251495/ https://www.ncbi.nlm.nih.gov/pubmed/32477499 http://dx.doi.org/10.1016/j.amsu.2020.05.009 |
work_keys_str_mv | AT piercejanetd potentialuseofubiquinolanddriboseinpatientswithheartfailurewithpreservedejectionfraction AT shenqiuhua potentialuseofubiquinolanddriboseinpatientswithheartfailurewithpreservedejectionfraction AT vacekjames potentialuseofubiquinolanddriboseinpatientswithheartfailurewithpreservedejectionfraction AT rahmanfaithk potentialuseofubiquinolanddriboseinpatientswithheartfailurewithpreservedejectionfraction AT kruegerkathrynj potentialuseofubiquinolanddriboseinpatientswithheartfailurewithpreservedejectionfraction AT guptabhanu potentialuseofubiquinolanddriboseinpatientswithheartfailurewithpreservedejectionfraction AT hiebertjohnb potentialuseofubiquinolanddriboseinpatientswithheartfailurewithpreservedejectionfraction |